HER2 Support Group Forums - View Single Post - Glaxo's experimental drug slows breast cancer spread by half

Susan2 · 06-05-2006, 01:17 PM

Remember that they stopped the study early which shortens the average time to recurrence - if the recurrence occurs. Only 28% recurred using Tykerb during the study period compared to 43% on Xeloda alone.

So using Tykerb and Xeloda, 72% did not recur during the study period. What that says to me is it that there is a population where is works and a population where it does not work - but we don't know what the distinction is.

Just my opinion, of course.

06-05-2006, 01:17 PM	#5
Susan2 Senior Member Join Date: Mar 2006 Posts: 87	Remember that they stopped the study early which shortens the average time to recurrence - if the recurrence occurs. Only 28% recurred using Tykerb during the study period compared to 43% on Xeloda alone. So using Tykerb and Xeloda, 72% did not recur during the study period. What that says to me is it that there is a population where is works and a population where it does not work - but we don't know what the distinction is. Just my opinion, of course.